Answers are grounded in this paper and cite their sources.
The correct management of the symptoms in patients suffering from musculoskeletal pain plays a key role in improving the quality of life. Acute pain or exacerbations in these patients may represent a functionally limiting symptom, the consequences of which should not be underestimated, not only for its impact on the patient’s quality of life but also for the risk of chronic pain. For an optimal control of musculoskeletal pain, a team of experts, orthopedic surgeons of the S.S.N., recommends a multimodal analgesic approach, which results in some pain relief and improved patient compliance to the prescribed treatment, minimisation of the doses of single components and consequently reduction in the adverse effects, mitigating the risk profile of each drug. In choosing the pharmacological association, it is suggested to adopt analgesics with different mechanisms of action. Paracetamol is the analgesic to be considered as a first choice for the treatment of mild to moderate acute pain and is preferred for long-term therapy, but if combined with ibuprofen allows reduce the dosages of both, with a drastic reduction in side effects related to NSAIDs. This combination has all the aforementioned advantages, guaranteeing the highest probability of pharmacological success in the management of mild to moderate pain present in some very common pathological situations such as post-traumatic sports and non-inflammatory inflammations, the exacerbation of chronic pain, the post-operative course of minor surgery and post-immobilization rehabilitation.
No takes yet. Share an insight, caveat, or question.
Gigliotti et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: